[HTML][HTML] Integration of a patient-centred MUO/CUP service within a new acute oncology service: challenges and rewards
S Dasgupta, WB Hyland, C Haughey… - Future Healthcare …, 2021 - ncbi.nlm.nih.gov
Background Holistic approach to the clinical management pathway for malignancy of
undefined primary origin (MUO)/carcinoma of unknown primary (CUP) patients remains an …
undefined primary origin (MUO)/carcinoma of unknown primary (CUP) patients remains an …
'No one Left Behind': The Introduction of a Formal Malignancy of Unknown Origin (MUO) Pathway in a Large Regional Cancer Centre
K Falconer, A Stavropoulos, A Tuck… - Clinical …, 2022 - clinicaloncologyonline.net
Background: Patients presenting with malignancy of unknown origin (MUO) are
disadvantaged in many ways. The 2010 National Institute for Health and Care Excellence …
disadvantaged in many ways. The 2010 National Institute for Health and Care Excellence …
[HTML][HTML] Characterisation and outcomes of patients referred to a regional cancer of unknown primary team: a 10-year analysis
M Stares, K Purshouse, G Knowles, R Haigh… - British Journal of …, 2021 - nature.com
Abstract Background In the United Kingdom, national guidance published in 2010
recommended the establishment of specialist teams to improve clinical pathways for patients …
recommended the establishment of specialist teams to improve clinical pathways for patients …
NICE guidance, but who does the work?
DNY Peel - Clinical Oncology, 2011 - clinicaloncologyonline.net
The latest clinical guidance from the National Institute for Health and Clinical Excellence
(NICE),'Diagnosis and management of metastatic malignant disease of unknown primary …
(NICE),'Diagnosis and management of metastatic malignant disease of unknown primary …
Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia
EL Boys, B Gao, P Grimison, S Sutherland… - Cancer …, 2024 - Wiley Online Library
Background Carcinoma of unknown primary (CUP) remains an important tumor entity and a
disproportionate cause of cancer mortality. Little is known about the contemporary clinical …
disproportionate cause of cancer mortality. Little is known about the contemporary clinical …
[HTML][HTML] Six-year experience of Australia's first dedicated cancer of unknown primary clinic
A van Mourik, G Tonkin-Hill, J O'Farrell… - British Journal of …, 2023 - nature.com
Background Diagnosis and management of cancers of unknown primary (CUP) remain
challenging. This study examines the referral patterns, management and outcomes of …
challenging. This study examines the referral patterns, management and outcomes of …
[PDF][PDF] Experiences of people with Cancer of Unknown Primary–what do we know and what do we need to do
P Schofield, H Gooden - The Australian Perspective Presentation …, 2012 - cupfoundjo.org
Aim: To determine clinical practices in approach to management of CUP amongst Australian
medical oncologists Design: Cross-sectional survey design using an electronically …
medical oncologists Design: Cross-sectional survey design using an electronically …
Cancer of unknown primary: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
A Krämer, T Bochtler, C Pauli, G Baciarello… - Annals of …, 2023 - annalsofoncology.org
CUP accounts for< 5% of cancers but, because of its high mortality rate, its relative
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …
Can Precision Oncology Benefit Patients With Cancers of Unknown Primary?
This editorial calls for a strategic shift in our approach to cancers of unknown primary (CUP),
one that generates a comprehensive multidimensional portrait of cancer in patients with …
one that generates a comprehensive multidimensional portrait of cancer in patients with …
[HTML][HTML] Redefining cancer of unknown primary: Is precision medicine really shifting the paradigm?
T Olivier, E Fernandez, I Labidi-Galy, PY Dietrich… - Cancer treatment …, 2021 - Elsevier
The concept of Cancer of Unknown Primary (CUP) has evolved with the advent of medical
oncology. CUP can be difficult to diagnose and represents 2 to 5% of new cancers, therefore …
oncology. CUP can be difficult to diagnose and represents 2 to 5% of new cancers, therefore …
Related searches
- challenges and rewards oncology service
- precision oncology unknown primary
- patients with cancers unknown primary
- clinical outcomes unknown primary
- institution perspective unknown primary
- experiences of people unknown primary
- patients with cancers precision oncology
- redefining cancer unknown primary
- people with cancer unknown primary
- cancer center unknown primary
- precision medicine unknown primary